These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 37611544)
1. Concurrent Cobalamin C and Plasminogen Deficiencies in a Patient with Chronic Thrombotic Microangiopathy. Dirim AB; Safak S; Balci MC; Ozyavuz P; Garayeva N; Tiryaki TO; Oto OA; Ozluk Y; Kilicaslan I; Solakoglu S; Artan AS; Yazici H; Turkmen A; Ozturk S Nephron; 2024; 148(1):54-62. PubMed ID: 37611544 [TBL] [Abstract][Full Text] [Related]
2. Comprehensive genetic analysis of complement and coagulation genes in atypical hemolytic uremic syndrome. Bu F; Maga T; Meyer NC; Wang K; Thomas CP; Nester CM; Smith RJ J Am Soc Nephrol; 2014 Jan; 25(1):55-64. PubMed ID: 24029428 [TBL] [Abstract][Full Text] [Related]
3. The roles of homocysteinemia and methylmalonic acidemia in kidney injury in atypical hemolytic uremic syndrome caused by cobalamin C deficiency. Wood WD; Elmaghrabi A; Gotway G; Wolf MTF Pediatr Nephrol; 2022 Jun; 37(6):1415-1418. PubMed ID: 34854955 [TBL] [Abstract][Full Text] [Related]
4. No association between dysplasminogenemia with p.Ala620Thr mutation and atypical hemolytic uremic syndrome. Miyata T; Uchida Y; Yoshida Y; Kato H; Matsumoto M; Kokame K; Fujimura Y; Nangaku M Int J Hematol; 2016 Aug; 104(2):223-7. PubMed ID: 27194432 [TBL] [Abstract][Full Text] [Related]
5. Distinct genetic profile with recurrent population-specific missense variants in Korean adult atypical hemolytic uremic syndrome. Yun JW; Oh J; Lee KO; Lee SJ; Kim JO; Kim NK; Kim JS; Koh Y; Yoon SS; Yhim HY; Jo SK; Park Y; Lee JE; Park J; Lee JW; Kim SH; Kim HJ; Oh D; ; Thromb Res; 2020 Oct; 194():45-53. PubMed ID: 33213850 [TBL] [Abstract][Full Text] [Related]
6. Thrombotic microangiopathy caused by methionine synthase deficiency: diagnosis and treatment pitfalls. Vaisbich MH; Braga A; Gabrielle M; Bueno C; Piazzon F; Kok F Pediatr Nephrol; 2017 Jun; 32(6):1089-1092. PubMed ID: 28210839 [TBL] [Abstract][Full Text] [Related]
7. Combined pulmonary hypertension and renal thrombotic microangiopathy in cobalamin C deficiency. Kömhoff M; Roofthooft MT; Westra D; Teertstra TK; Losito A; van de Kar NC; Berger RM Pediatrics; 2013 Aug; 132(2):e540-4. PubMed ID: 23837176 [TBL] [Abstract][Full Text] [Related]
8. Case report: Novel FHR2 variants in atypical Hemolytic Uremic Syndrome: A case study of a translational medicine approach in renal transplantation. Stea ED; Skerka C; Accetturo M; Pesce F; Wiech T; Hartman A; Pontrelli P; Conserva F; Castellano G; Zipfel PF; Gesualdo L Front Immunol; 2022; 13():1008294. PubMed ID: 36451836 [TBL] [Abstract][Full Text] [Related]
9. Defining the genetics of thrombotic microangiopathies. Vieira-Martins P; El Sissy C; Bordereau P; Gruber A; Rosain J; Fremeaux-Bacchi V Transfus Apher Sci; 2016 Apr; 54(2):212-9. PubMed ID: 27177491 [TBL] [Abstract][Full Text] [Related]
10. Thrombotic microangiopathy: focus on atypical hemolytic uremic syndrome. Sperati CJ; Moliterno AR Hematol Oncol Clin North Am; 2015 Jun; 29(3):541-59. PubMed ID: 26043391 [TBL] [Abstract][Full Text] [Related]
11. Hemolytic uremic syndrome with dual caution in an infant: cobalamin C defect and complement dysregulation successfully treated with eculizumab. Barlas UK; Kıhtır HS; Goknar N; Ersoy M; Akcay N; Sevketoglu E Pediatr Nephrol; 2018 Jun; 33(6):1093-1096. PubMed ID: 29558000 [TBL] [Abstract][Full Text] [Related]
12. Whole exome sequencing revealed a novel homozygous variant in the DGKE catalytic domain: a case report of familial hemolytic uremic syndrome. Gholizad-Kolveiri S; Hooman N; Alizadeh R; Hoseini R; Otukesh H; Talebi S; Akouchekian M BMC Med Genet; 2020 Aug; 21(1):169. PubMed ID: 32838746 [TBL] [Abstract][Full Text] [Related]
13. Novel Complement Factor B Gene Mutation Identified in a Kidney Transplant Recipient with a Shiga Toxin-Triggered Episode of Thrombotic Microangiopathy. Korzycka J; Pawłowicz-Szlarska E; Masajtis-Zagajewska A; Nowicki M Am J Case Rep; 2022 Oct; 23():e936565. PubMed ID: 36306276 [TBL] [Abstract][Full Text] [Related]
14. Characterization of a New DGKE Intronic Mutation in Genetically Unsolved Cases of Familial Atypical Hemolytic Uremic Syndrome. Mele C; Lemaire M; Iatropoulos P; Piras R; Bresin E; Bettoni S; Bick D; Helbling D; Veith R; Valoti E; Donadelli R; Murer L; Neunhäuserer M; Breno M; Frémeaux-Bacchi V; Lifton R; Remuzzi G; Noris M Clin J Am Soc Nephrol; 2015 Jun; 10(6):1011-9. PubMed ID: 25854283 [TBL] [Abstract][Full Text] [Related]
15. Genetic Analysis of 400 Patients Refines Understanding and Implicates a New Gene in Atypical Hemolytic Uremic Syndrome. Bu F; Zhang Y; Wang K; Borsa NG; Jones MB; Taylor AO; Takanami E; Meyer NC; Frees K; Thomas CP; Nester C; Smith RJH J Am Soc Nephrol; 2018 Dec; 29(12):2809-2819. PubMed ID: 30377230 [TBL] [Abstract][Full Text] [Related]
16. Post-Transplant Thrombotic Microangiopathy due to a Pathogenic Mutation in Complement Factor I in a Patient With Membranous Nephropathy: Case Report and Review of Literature. Saleem M; Shaikh S; Hu Z; Pozzi N; Java A Front Immunol; 2022; 13():909503. PubMed ID: 35720299 [TBL] [Abstract][Full Text] [Related]
17. CFH-CFHR1 hybrid genes in two cases of atypical hemolytic uremic syndrome. Sugawara Y; Kato H; Nagasaki M; Yoshida Y; Fujisawa M; Minegishi N; Yamamoto M; Nangaku M J Hum Genet; 2023 Jun; 68(6):427-430. PubMed ID: 36755127 [TBL] [Abstract][Full Text] [Related]
18. Isolated thrombotic microangiopathy of the small intestine in a patient with atypical hemolytic uremic syndrome - a case report. Nunius C; Büttner-Herold M; Bertz S; Schiffer M; Buchholz B BMC Nephrol; 2020 Mar; 21(1):104. PubMed ID: 32204691 [TBL] [Abstract][Full Text] [Related]
19. Thrombotic microangiopathy without renal involvement: two novel mutations in complement-regulator genes. Peyvandi F; Rossio R; Ferrari B; Lotta LA; Pontiggia S; Ghiringhelli Borsa N; Pizzuti M; Donadelli R; Piras R; Cugno M; Noris M J Thromb Haemost; 2016 Feb; 14(2):340-5. PubMed ID: 26613809 [TBL] [Abstract][Full Text] [Related]
20. Statistical Validation of Rare Complement Variants Provides Insights into the Molecular Basis of Atypical Hemolytic Uremic Syndrome and C3 Glomerulopathy. Osborne AJ; Breno M; Borsa NG; Bu F; Frémeaux-Bacchi V; Gale DP; van den Heuvel LP; Kavanagh D; Noris M; Pinto S; Rallapalli PM; Remuzzi G; Rodríguez de Cordoba S; Ruiz A; Smith RJH; Vieira-Martins P; Volokhina E; Wilson V; Goodship THJ; Perkins SJ J Immunol; 2018 Apr; 200(7):2464-2478. PubMed ID: 29500241 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]